Accès gratuit
Numéro
Med Sci (Paris)
Volume 25, Numéro 1, Janvier 2009
Page(s) 64 - 68
Section M/S revues
DOI https://doi.org/10.1051/medsci/200925164
Publié en ligne 15 janvier 2009
  1. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346 : 2053–60.
  2. Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in feto-maternal allo-immunization and neonatal glomerulopathies. Lancet 2004; 364 : 1252–9.
  3. Hörl WH, Kerjaschki D. Membranous glomerulonephritis (MGN) J Nephrol 2000; 13 : 291–316.
  4. Cunningham PN, Quigg RJ. Contrasting roles of complement activation and its regulation in membranous nephropathy. J Am Soc Nephrol 2005; 16 : 1214–22.
  5. Platt JL, Grant BW, Eddy AA, Michael AF. Immune cell populations in cutaneous delayed-type hypersensitivity. J Exp Med 1983; 158 : 1227–42.
  6. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003; 21 : 3365–9.
  7. Clark MR. IgG effector mechanisms. Chem Immunol 1997; 65 : 88–110.
  8. Turner AJ, Brown CD, Carson JA, Barnes K. The neprilysin family in health and disease. Adv Exp Med Biol 2000; 477 : 229–40.
  9. Ikeda K, Emoto N, Raharjo SB, et al. Molecular identification and characterization of novel membrane-bound metalloprotease, the soluble secreted form of which hydrolyzes a variety of vasoactive peptides. J Biol Chem 1999; 274 : 32469–77.
  10. Bonvouloir N, Lemieux N, Crine P, et al. Molecular cloning, tissue distribution, and chromosomal localization of MMEL2, a gene coding for a novel human member of the neutral endopeptidase-24.11 family. DNA Cell Biol 2001; 20 : 493–8.
  11. Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol 2005; 16 : 1205–13.
  12. Whitington PF, Kelly S. Outcome of pregnancies at risk for neonatal hemochromatosis is improved by treatment with high-dose intravenous immunoglobulin. Pediatrics 2008; 121 : e1615–21.
  13. Nortier JL, Debiec H, Tournay Y, et al. Neonatal disease in neutral endopeptidase alloimmunization: lessons for immunological monitoring. Pediatr Nephrol 2006; 1 : 1399–405.
  14. Collinet P, Subtil D, Puech F, Vaast P. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization. Obstet Gynecol 2002; 100 : 1102–5.
  15. Ruggenenti P, Chiurchiu C, Brusegan V, et al. Rituximab in idiopathic membranous nephropathy: a one-year prospective study. J Am Soc Nephrol 2003; 14 : 1851–7.
  16. Reynolds J, Prodromidi EI, Juggapah JK, et al. Nasal administration of recombinant rat alpha3(IV)NC1 prevents the development of experimental autoimmune glomerulonephritis in the WKY rat. J Am Soc Nephrol 2005; 16 : 1350–9.
  17. Hall AM, Cairns LS, Altmann DM, et al. Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice. Blood 2005; 105 : 2175–9.
  18. Monteiro RC, Leroy V, Launay P, et al. Pathogénie de la maladie de Berger : Implication des immunoglobulines A et de leurs récepteurs. Med Sci (Paris) 2003; 19 : 1233–41.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.